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Abstract 
Purpose: Quantitative diffusion MRI has frequently been studied as a means of grading 
prostate cancer. Interpretation of results is complicated by the nature of prostate tissue which 
consists of four distinct compartments: vascular, ductal lumen, epithelium and stroma. 
Current diffusion measurements are an ill-defined weighted average of these compartments. 
Here prostate diffusion is analyzed in terms of a model that takes explicit account of tissue 
compartmentalization, exchange effects and the non-Gaussian behaviour of tissue diffusion.  
Methods: The model assumes exchange between the cellular (i.e., stromal plus epithelial) 
and the vascular and ductal compartments is slow. Ductal and cellular diffusion 
characteristics are estimated by Monte Carlo simulation and a two-compartment exchange 
model respectively. Vascular pseudo-diffusion is represented by an additional signal at b = 0. 
Most model parameters are obtained either from published data or by comparing model 
predictions with published results from 41 studies. Model prediction error is estimated using 
10-fold cross-validation. 
Results: Agreement between model predictions and published results is good. The model 
satisfactorily explains the variability of ADC estimates found in the literature. 
Conclusions: A reliable model that predicts the diffusion behaviour of benign and cancerous 
prostate tissue of different Gleason scores has been developed. 
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Introduction 
Prostate cancer is the second most common cancer in men worldwide [1] and the most 
common cancer in US men [2]. It is the fifth leading cause of death from cancer in men 
worldwide [1] and the second leading cause of death in US men [2]. Despite these mortality 
statistics, most prostate tumours are indolent, low-grade tumours that will have no clinical 
consequences. The best assessment of tumour aggressiveness is the Gleason score obtained 
from whole-mount histology of the surgically excised prostate [3-5]. However, pre-surgical 
Gleason scores obtained from trans-rectal biopsy samples are much less reliable due to the 
inability to sample the whole prostate (sampling error) [6-9]. As a result prostate cancer is 
over-treated and it is currently estimated that as many as 37 men undergo prostatectomy for 
every cancer death prevented [10]. This not only entails great unnecessary expense and 
suffering, but the incidence of morbidity associated with the procedure (principally urinary 
and sexual dysfunction) is very high (up to 90%) [11]. Improved methods of assessing 
prostate tumours could greatly reduce the expense, anxiety and morbidity associated with 
excessive treatment. 
Histology: Gleason score and grade 
Histologically, the prostate consists of four distinct compartments or cell types: vascular (i.e., 
capillaries), fibro-muscular stroma, epithelium and glandular lumen. Vascular volume in the 
normal peripheral zone of the prostate is about 2% [12]. Of the remaining tissue 
approximately 39.5% is stroma, 31.5% epithelium and 29% ductal lumen [13]. The epithelial 
cells form the walls of the glandular ducts and separate them from the stroma. In tumours, the 
stromal and lumenal fractions decrease and the vascular and epithelial fractions increase; 
these changes are progressive with tumour aggressiveness. 
Tumours are assigned a Gleason score as follows: each tumour is given two Gleason grades 
based on histological pattern of the two dominant tumour areas and these are then summed to 
give the Gleason score. Scores of less than 6 are considered low grade. It is thus most 
important to distinguish between Gleason grades 3, 4 and 5 [3]. Lumen volume decreases 
with grade by ~12% for Gleason 3, ~16% for Gleason 4 and ~21% for Gleason 5 [13]. The 
ratio of epithelial to stromal volumes doubles between grades 3 and 5 (~1.4 for Gleason 3, 
~2.8 for Gleason 5). Furthermore, the density of epithelial cells also increases. Thus 
measurements of lumenal volume and cellular composition have great potential to provide a 
reliable means of identifying grade. 
Quantitative Diffusion MRI 
The use of quantitative diffusion magnetic resonance imaging (MRI) for assessment of 
prostate cancer has been investigated by many groups [14-43].  However, although there are 
clear differences in MRI parameters between tumours and normal prostate, differences 
between high and low grade tumours are small with considerable overlap. Quantitative 
measurements in the prostate are complicated by the complex nature of prostate tissue 
described above. In addition, blood flow in tortuous capillaries can lead to a “pseudo-
diffusion” signal such as seen in intra-voxel, incoherent motion (IVIM) experiments. 
However, to date the heterogeneity of prostate tissue has not generally been taken into 
account and MRI parameter estimates represent a weighted average of the contributions of 
the different compartments.  
In this paper we propose a model of prostate tissue diffusion that takes tissue 
compartmentalisation explicitly into account. By doing so, not only are ambiguities in 
previous measurements resolved, but also estimates of ductal, stromal and endothelial 
volumes become possible. Since these are the most important factors determining Gleason 
grade, this approach could provide an equivalent MRI score that might distinguish aggressive 
and indolent tumours. Furthermore, since this is an imaging method that can cover the whole 
prostate it avoids sampling error and could therefore provide greatly improved pre-operative 
assessment. 
Tissue Model 
The model is based on measured or estimated values for the different tissue volumes and 
diffusion coefficients in normal prostate and cancer. The net signal arising from the tissue 
will depend on these parameters and on the exchange of water between different 
compartments. If exchange is slow relative to the time over which the signal is acquired 
(typically 50–100 ms), then each water molecule will effectively be confined to a single 
compartment and will contribute a signal characteristic of that compartment alone. 
Conversely, if water exchange is very fast between two compartments they are well mixed 
and cannot be distinguished. At intermediate exchange rates, water molecules will spend time 
in both compartments and will contribute a signal that represents an average between them. 
In normal prostate the glandular lumen is 300μm in radius [44] compared with typical water 
diffusion distances of ~20 μm (assuming a total diffusion time of 80ms, typical of clinical 
scanners, and diffusion coefficient of 3 μm2ms-1, similar to that of water [45, 46]). Thus 
exchange of water between the lumen and the cellular (i.e., epithelial plus stromal) 
compartments is expected to be small. With increasing Gleason grade the lumenal volume 
decreases. Nonetheless, exchange between the two is likely to remain slow [44]. Similarly, 
the observation of an IVIM signal in most tissues suggests that exchange between the intra- 
and extra-vascular compartments is also slow [47]. Stromal and epithelial layers are relatively 
thin so that exchange will be significant but the two cannot be considered well mixed. The 
validity of these assumptions is confirmed by the finding of biexponential, but not 
triexponential T2s in the prostate [48]. Our model (Fig. 1) is based on these assumptions, i.e., 
slow exchange between intra- and extravascular compartments; slow exchange between 
ductal and cellular compartments; moderate exchange between stroma and epithelium. 
With this model, the total signal, S, is the sum of the signals from each slow-exchanging 
compartment, i.e.: 
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where Si is the signal from compartment i and the subscripts v, d and c indicate the vascular, 
ductal lumen and cellular compartments respectively.  
Vascular Signal 
The vascular fraction is small and becomes rapidly dephased at even low b values due to the 
relative rapidity of capillary flow [49]. Sv can thus be approximated by a delta function at b = 
0. 
Ductal signal 
Both cellular and ductal compartments will display non-Gaussian diffusion (i.e., the 
probability density function describing diffusional motion is non-Gaussian) and so in 
principle should include a kurtosis term. The signal Si from compartment i  (i = d or c) is then 
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where Si0 is the signal in the absence of diffusion weighting, Di is the apparent diffusion 
coefficient (ADC), Ki is the apparent kurtosis and O(b
3) indicates terms on the order of b3. In 
this report we use ADC to refer to any measured diffusion coefficient since all expressions 
relating signal to b value involve approximations. However, Monte Carlo simulations of 
semi-permeable cavities suggest that the ductal kurtosis term will contribute no more than 1% 
of the total ductal signal [44]. Consequently, although ductal kurtosis measurements might 
provide useful information in principle, it is unlikely that the SNR of measurements will be 
sufficient for their accurate measurement. We have therefore assumed Gaussian ductal 
diffusion in our model. 
Total signal is therefore given by 
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where S0 is the signal without diffusion weighting, fi is the signal fraction of compartment i, 
(so that fv + fd + fc = 1), Di is the apparent diffusion coefficient of compartment i, δ is the 
Dirac delta function, and b is the diffusion weighting constant. 
We have previously shown that the reductions in lumenal diameter found in prostate cancer 
reduce Dd [44]. Values can be described approximately by the following biexponential 
function 
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rd is the lumenal radius (μm), TTD is the total diffusion time and  
D
d
free  is the diffusion 
coefficient in the absence of barriers. (See below for a discussion of the distinction between 
total diffusion time and diffusion time.) 
Cellular Signal 
The cellular compartment consists of the stroma and epithelial sub-compartments. Exchange 
between these sub-compartments is intermediate between fast and slow. In such 
circumstances diffusion behaviour is complex. Jensen et al. [50] have shown that the 
behaviour can be approximated by monoexponential diffusion with a kurtosis term (Eq. [2]).  
The cellular diffusion and kurtosis are then [50-52] 
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where Dc
nox and Kc
nox are the diffusion coefficient and kurtosis with no exchange, TD is the 
diffusion time, and τ is the exchange time between stromal and epithelial sub-compartments. 
Dc
nox and Kc
nox are the given by 
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where vi is the water volume fraction of compartment i and subscripts s and e refer to the 
stromal and epithelial sub-compartments respectively. The exchange time, τ, is given by 
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where τs and τe are the stromal and epithelial residence times respectively. 
Thus, the diffusion coefficient of the cellular compartment is the average of the individual 
stromal and epithelial diffusion coefficients weighted by the relative amounts of water in 
each; the kurtosis is similarly a weighted measure of the variance of the diffusion 
coefficients. When TD >> τ, the compartments are effectively in fast exchange, are well 
mixed and behave as a single monoexponential compartment with Kc close to zero. 
Diffusion Time 
Note the distinction between the total diffusion time, TTD, and diffusion time, TD, as normally 
defined in the MRI literature. TTD is the total period over which diffusion affects the outcome 
of the experiment 
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where δ is the length of the diffusion gradients and Δ is the interval between their centers. TD 
is a convenient constant that arises when calculating gradient b values 
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Diffusion time also occurs in other MRI diffusion equations, such as that for kurtosis, Eq. [7]. 
However, these expressions often only strictly apply when δ << Δ. In most in vivo imaging 
sequences the diffusion gradients are applied for as long as possible to maximize b for a 
given echo time. It has recently been suggested [53] that in these circumstances TD is better 
approximated by  
 
T
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Diffusion time is not in any case generally available (and is usually unknown to all but the 
sequence designers). In developing the model we have therefore used the same 
approximation for TD (in Eq. [7]) and TDF (in Eq. [5])   
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This is based on the assumption that echo times have been minimized to improve SNR and a 
few milliseconds are required for the EPI imaging gradients following diffusion weighting.  
Model Parameters 
The parameters that define the model are of two types. First, there are a priori parameters that 
are derived from literature values. Second are parameters for which no reliable estimates can 
be found. These are optimized by minimization of the mean square error (MSE) between 
model predictions and measured values. 
The vascular, stromal, epithelial and ductal fractional volumes, and ductal radius of benign 
and cancerous prostate tissue were defined a priori using literature values [13, 44]  (Table 1). 
Vascular volumes are based on the measurements of Schlemmer at al.[12] who found 
vascular volumes of 2% in normal peripheral zone, rising to 4% in prostate cancer. Gleason 
score was not specified so the value of 4% was assumed to correspond to Gleason 7 and other 
values derived using linear interpolation and extrapolation.  
The difference in water density between the vascular, ductal and cellular compartments and 
differences in transverse relaxation time must also be taken into account when calculating 
signal fractions from volume fractions. In the absence of diffusion weighting, the signal from 
compartment i, is  
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where k is a constant describing system gain, ρi is water spin density (water hydrogen atoms 
per unit volume), vi is the volume fraction, TE is the echo time of the diffusion sequence and 
T2i is the transverse relaxation time. The fractional signal from compartment i, fi, is therefore 
the ratio of Si0 to the sum of the signals from all compartments, i.e., 
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The glandular fluid contains few solids so that water content is ~100% whereas most soft 
tissues have a water content of about 75% [54, 55] and blood is about 80% water [56]. Long 
and short T2s, which we assume correspond to the ductal and cellular (i.e., stromal plus 
epithelial) fractions respectively, have been measured to be about 450 ms and 60 ms [48, 57]. 
The T2 of blood is about 280ms and largely independent of field strength [58]. Signal 
fractions calculated from Eq. [16] using the above figures are given in Table 1. 
It is not simple to obtain independent estimates of ductal, stromal and epithelial diffusion 
coefficients in vivo. Ex vivo MRI measurements in formalin fixed tissue at 22°C give 
diffusion coefficients of 2.0-2.2, 0.7-0.9 and 0.3-0.5 μm2ms-1 for ducts, stroma and 
epithelium respectively [59, 60]. However, changes in diffusion characteristics due to cell 
death, fixation and temperature differences make these measurements difficult to interpret 
[61-63]. Several studies have reported biexponential diffusion measurements in normal PZ 
[64-66]. However, the fast and slow diffusion coefficients (presumably corresponding to 
glandular and cellular diffusion respectively) covered very large ranges: 2.5 – 8.8 and 0.2 – 
1.2 μm2ms-1 respectively. The fast diffusion coefficient is difficult to interpret because it 
includes perfusion signals (the IVIM effect) and variations in this measurement will also 
affect the slow diffusion estimate. The values of Ds and De that gave the best agreement 
between the model and experimental results were therefore found empirically (see below). 
Cellular kurtosis depends on the ratio of diffusion time to the exchange time between stroma 
and epithelium. Exchange time is also unknown but can be estimated from the average 
diffusion distance [67]: 
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If we assume that τ is approximately the time it takes to diffuse from the centre of the stromal 
or epithelial layer to its edge, then 
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where rc is half the thickness of either the epithelial or stromal layer. 
Diffusion coefficients are inversely correlated with cell density [68, 69] and consequently 
reduced in tumours. The precise relationship between ADC and cancer grade is unknown but 
ADC values typically decrease with increasing grade, dropping to about 50% of normal 
values in high-grade tumors [70-72]. We therefore assumed that the epithelial diffusion 
coefficient De drops linearly with Gleason score from a value De
norm at Gleason 0 (i.e., 
normal) to 0.5De
norm
 at Gleason 10, i.e.,  
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where g is the Gleason score.  
Finally, as prostate tumours primarily involve epithelial cells, we assumed that the stromal 
diffusion coefficient is independent of grade, 
 
D
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where Ds
norm
 is the diffusion coefficient of normal stroma. 
The model is thus Eq. [3] with Dd given by Eq. [4], Dc by Eq. [6], and Kc by Eq. [7], with 
signal fractions given by Eq. [16]. 
Materials and Methods 
Only published data was used for this study so no ethical consent was sought. 
Epithelial Thickness 
To obtain the estimate of stromal/epithelial exchange times, for use in Eq. [7], the average 
thickness of epithelial cells was estimated by making measurements from histology images of 
normal and cancerous prostate [73] using ImageJ [74].  
Optimum Compartmental Diffusion Coefficients, Di 
Forty-three papers were identified that presented diffusion measurements with associated 
Gleason scores [14-43, 75-87] and included b values. (No attempt was made to perform an 
exhaustive search and this does not represent a complete list of prostate diffusion studies.) In 
three studies, field strength was not reported and was assumed to be 3T [14, 17, 41]. Studies 
were divided into two categories according to the precision with which Gleason score was 
specified: 
I ADC recorded for individual Gleason scores. 
II ADCs recorded for groups with an average (mean or median) Gleason score. 
Where separate ADC estimates were made for, e.g., Gleason 3+4 and 4+3, each measurement 
was included separately with a grade of 7. Similarly, when measurements for multiple readers 
were reported, each was treated as a separate measurement. In one case tertiary Gleason 
grades were given [21] but were ignored.  
In all studies, measurements were made at two or more b values and ADCs were estimated 
assuming a single compartment displaying Gaussian diffusion so that signals were assumed 
to be given by 
. [21] 
These data were used to find the values of the compartmental diffusion coefficients (i.e., 
Dd
free, De
norm
, and Ds
norm), that maximise agreement with the model predictions. Fig. 2 gives a 
flow chart outlining the process. The initial data is derived from the published data. Gleason 
score and b values were passed to the model and used to generate a set of signals, S(b) using 
Eq. [3], with trial values of Di. Eq. [21] is then fitted to the model signal to obtain model 
estimates of ADC, Dmodel. Non-linear least squares fitting (Matlab function lsqcurvefit) is 
then used to find the set of Di that minimize mean-square error, MSE, 
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 . [22] 
where ΔD is the difference between measured and model ADC and the sum is over each 
measurement in the published data sets. 
The above procedure was initially performed over all data sets to find an initial set of 
optimum Di. The difference, ΔD, was calculated for all measurements and the mean and 
standard deviation of the differences found. Differences that were greater than 1.96 standard 
deviations away from the mean were considered outliers. Any data sets containing more than 
one outlier was removed from the analysis set since this suggested the possibility of a 
systematic error such as incorrectly calibrated b values. The optimization procedure was then 
repeated with the reduced set to generate the final results. 
Cross-validation 
Cross-validation was performed using 10-fold cross-validation [88]. Briefly, all tissue 
measurements from the 43 studies were collected into a single set of N measurements. This 
set was split into 10 folds, each with a group of ~N/10 test points used for testing with the 
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remaining points used for training. Each training group is used to find a set of optimum Di. 
The differences between Dmeasured and Dmodel were then found for all points in the test group 
using these parameters. The process was repeated for each fold and the MSE found over all 
test points in all folds. This method provides a moderately conservative estimate of the true 
MSE. 
Results 
Epithelial Thickness 
Average epithelial thickness was 8.2±1.3 µm (12 measurements) and 18.3±5.4 µm (7 
measurements) for healthy prostate and Gleason score 7, respectively. This gives an estimate 
of τ = 50ms from Eq. [18], assuming rc (half thickness of the cellular layer) is ~10µm, and 
the cellular diffusion coefficient is 1 μm2ms-1. 
Compartmental Diffusion Coefficients 
Two of the 43 papers produced more than one outlier each and were removed leaving 41 
papers and a total of 140 different diffusion measurements. Optimum values of Dd
free, Ds
norm 
and De
norm for this reduced set were 2.368, 1.222 and 0.571 μm2ms-1 respectively.  
Figs. 3 and 4 gives plots comparing measured values of diffusion coefficient with values 
predicted by the model. Fig. 3 is plot of Dmeasured vs. Dmodel; Fig. 4 is a Bland-Altman plot of 
ADC difference vs. mean ADC. As might be expected field strength shows little or no 
influence on the measurements. There appears to be a slight suggestion that the scatter is 
greater for Category II than Category I as might be expected. Overall agreement is very good 
and the 10-fold cross-validation gave an MSE of 0.046 equivalent to a root MSE of 0.21 
μm2ms-1  
Fig. 5 gives plots of Dd, Ds, De, Dc and Kc vs. Gleason score. (Diagnostically the most 
important distinction is between scores of less than and greater than six.) 
Fig. 6 gives a plot of signal intensity predicated by the model vs. b value for normal prostate 
and Gleason scores 5 – 9.  
Discussion 
The value of an accurate model of tissue diffusion is fourfold. First, it allows association of 
diffusion measurements with specific cellular changes, which may have valuable diagnostic 
implications. In this case, diffusion changes are direct consequences of changes in the relative 
volumes of ductal lumen, stroma and epithelium. These volumes are a key aspect of 
histopathological analysis and largely determine Gleason score. Hence estimates from 
diffusion measurements may allow calculation of an “MR Gleason Score” that predicts 
tumour aggressiveness. Second, knowing how changes in individual tissue compartments 
influence signal changes allows optimization of acquisitions (specifically choice of b values) 
to minimize errors in tissue estimates. Thirdly, a model simplifies fitting procedures. 
Increasing the number of parameters in a model will inevitably reduce the size of the 
residuals but increases the risk of overfitting (i.e., fitting to noise). Moreover, multiple 
parameters which have similar effects on the signal can lead to instabilities when two entirely 
different parameters sets can produce similar fits. This is a notorious problem in fitting 
biexponential signals. However, the model we propose has only a single free parameter – the 
Gleason score. Finally, the model explains the contradictions and ambiguities found in the 
literature. For example, a number of studies have described the b value dependence of 
measured ADCs [18, 27, 38, 75]. However, this is entirely to be expected as a linear 
relationship between ln(S) and b will only be found for diffusion in a single Gaussian 
compartment. In any more complex system, the ln(S) vs. b is non-linear and cannot be 
described by a single ADC (i.e., a single value for the slope). The problem is particularly 
acute in the prostate since the two main compartments, ductal and cellular, have markedly 
different diffusion coefficients. The optimum prostate diffusion protocol is not then a simple 
matter of finding a single optimum b value [89] but of acquiring images at a sufficiently large 
number of b values to fully describe the data. Similarly, the model explains the finding of a 
lowered IVIM “perfusion fraction” in tumours [64, 90]. This finding is not only 
counterintuitive since tumour angiogenesis generally increase blood volume, it is also 
contradictory to DCE perfusion measurements [90]. However, changes in signal at low b 
values are determined by two components: flowing blood displaying pseudo-diffusion and 
signal from the rapidly diffusing ductal compartment. The latter is reduced in cancer resulting 
in a reduction in the signal labelled perfusion fraction in IVIM experiments. 
Others have previously investigated multi-exponential diffusion in the prostate. The Mulkern 
group observed bi-exponential diffusion behaviour in both normal prostate [65] and cancer 
[84] but offered no explanation of its origin. Bourne and colleagues [91] also observed bi-
exponential diffusion in fixed samples. Panagiotaki et al. [29] previously proposed a three 
compartment model consisting of vascular (i.e., IVIM), intracellular and extracellular 
compartments. However, previous attributions of biexponential behaviour to intra- and 
extracellular compartments in the brain have been questioned for a number of reasons. First, 
it is unnecessary since non-Gaussian diffusion will always occur in the presence of hindered 
diffusion [50]. Second the signal fractions do not agree with known intra- and extracellular 
volumes obtained by other means [92, 93]. Third, magnetization transfer rates are similar for 
both components which would not be expected for intra- and extracellular water [94]. 
Furthermore, if the two non-vascular diffusion components are assigned to intra- and 
extracellular spaces in the prostate then the cellular and ductal signals must be well mixed. 
This is biophysically difficult to explain and we believe that ductal/cellular 
compartmentalization is a more plausible explanation of bi-exponential diffusion behaviour.  
Several groups have also used non-Gaussian fits, either with a kurtosis term or using a 
stretched exponential equation to describe diffusion in the prostate [32, 34, 91]. These 
methods will naturally provide better fits than simpler models. However, without explicitly 
taking into account the multi-compartment nature of the prostate, these models provide little 
biophysical insight into the relationship between diffusion measurements and the changes 
that occur in cancer.  
The IVIM signal in this model is described by a delta function at b = 0. I.e., it is assumed that 
any diffusion weighting effectively eliminates the perfusion signal. This is a simplification 
and it might be possible to develop a more accurate model with a pseudo-diffusion term that 
would help in diagnosis. However, there are a number of problems with this approach. First, 
the perfusion signal is very sensitive to low b values. However, the “b = 0” signal includes a 
small amount of diffusion weighting due to the imaging gradients. This is especially true with 
the large, repeated gradient pulses that are used in the EPI sequences. This introduces errors 
into estimates of the pseudo-diffusion parameters. Second, although blood volume is 
increased with tumour angiogenesis, it is not certain that blood flow is also increased since 
increased interstitial pressure caused by hyperpermeable vessels can retard flow decreasing 
the IVIM signal [95-97]. Given the difficulty in interpretation we think it preferable to use b 
~150smm-2 for the “b = 0” signal.  
Our results primarily show that the diffusion properties of benign and cancerous prostate 
tissue can be described by a simple model. Most model parameters were defined a priori 
using non-MRI data. Three, Dd
free, Ds
norm, and De
norm
, were obtained by fitting the model to 
empirical data. The estimated values seem reasonable. Dd
free is somewhat lower than that of 
free water at 37°C (3.08 μm2ms-1) [45, 46] and is similar to the ex vivo estimate of Bourne et 
al. [60]. Ds
norm and De
norm are both of the same order as the slow ADCs found by Shinmoto et 
al. [84]. Furthermore, the relative sizes are similar to those found by Bourne et al. [59] in 
fixed tissue and are consistent with histological observations of greater cell density in 
epithelium than in stroma [20]. All the a priori parameters are subject to noise and could 
undoubtedly be improved with further experiment. 
One interesting implication of this study is that diffusion values are a product of the diffusion 
coefficients of the individual tissue types and Gleason score alone. Gleason score can, in 
principle, be determined by a diffusion measurement using only two b values provided the 
minimum is sufficient to completely dephase the IVIM signal (Fig. 6). However, as is well 
known, noise in these measurements is relatively large. Furthermore changes in Gleason 
score affect the shape of the signal curve, not just the overall decay rate so that multiple b 
values will help in accurately determining Gleason score. 
There are a number of limitations of this study. First, and most importantly, the data to 
construct and test the model were obtained from the literature. Our approach has the 
advantage that the model is tested against a very large body of data, acquired with multiple 
different protocols, thus demonstrating the generality of model predictions. Similarly, the 
success of model predictions demonstrates that it is capable of explaining many of the 
ambiguities and contradictions in the literature. However, it would be better to construct the 
model from measurements specifically designed for the purpose (i.e., to characterize Dd
free, 
Ds
norm and De
norm) and to test the model by comparing signal predictions against actual signal 
measurements. We are currently acquiring data for this purpose. Second, the histological 
diagnoses reported were derived from either biopsy samples or post-surgical whole-mount 
histology. It is well known that the former are much less reliable than the latter due to 
sampling error [6-9]. Similarly association between diffusion measurements and the 
corresponding histopathological assessments was by a variety of different methods (quadrant 
by quadrant, MRI visible abnormality vs. overall Gleason score, etc.). Optimally, 
comparisons should be made between co-registered histological and MRI images. Third, 
some model parameters were estimated by informed guesswork rather than direct 
measurement. In particular, diffusion in cancerous epithelium was assumed to decrease 
linearly with Gleason score to a minimum of 50% of normal. Neither linearity nor the 
magnitude of the effect can be fully justified. A more complex relationship is probable given 
the complexity of biological processes and certainly has the potential to improve agreement 
between model and measurement. However, we believe it is unlikely to provide substantial 
improvement given the noise levels involved, and runs the danger of over-fitting. The 
maximum reduction of 50% is also a guess but within the range reported in the literature for 
other tumours. However, all estimated parameters should be replaced, where possible, by 
direct measurement. (Some could also be made free parameters of the model but the 
advantage of this approach would be offset by the danger of overfitting.) Similarly, several 
model parameter estimates were obtained by linear interpolation between known 
measurements at particular Gleason scores. Although, replacement by direct measurements 
should improve the model, we believe the difference is likely to be a relatively small. Finally, 
there are limitations to the Jensen/Kärger exchange model that have been investigated in 
Fieremans et al. [98]. Although the model appears accurate for brain tissue, it is not clear that 
this is so in the cellular compartment of prostate. Additionally both stroma and epithelium 
consist of cellular and extra-cellular compartments potentially with a corresponding kurtosis 
term. Considerably more work is required to elucidate these issues. Nonetheless, the 
predicted range of Kc appears reasonable and, since Kc has only second order effects on 
diffusion signal, any errors are unlikely to be seriously detrimental to the model presented 
here. 
  
Table 1. Tissue fractional volumes, vi, signals, fi, and ductal radii, rd, used in the model for 
benign peripheral zone (PZ) and different Gleason scores. Fractional vascular volumes are 
interpolated from Schlemmer assuming that the measured value of vv for cancer refers to 
Gleason 7. Other fractional volumes are derived from measurements made by Chatterjee et 
al.[13] for different Gleason grades. The value for Gleason score 7, for example, was 
obtained by averaging measurements for Gleason grades 3 and 4. Lumenal radius was 
obtained from Gilani et al. [44]. Interpolation was used when measurements were missing for 
individual scores. 
Tissue 
Fractional Volumes (Signals) Ductal 
radius, 
rd / μm Vascular Ductal lumen Stroma Epithelium 
Normal PZ 0.020 (0.031) 0.284 (0.614) 0.382 (0.195) 0.314 (0.160) 300 
Gleason 1 0.023 (0.037) 0.264 (0.588) 0.365 (0.192) 0.349 (0.184) 258 
Gleason 2 0.026 (0.043) 0.244 (0.561) 0.357 (0.194) 0.373 (0.202) 216 
Gleason 3 0.029 (0.050) 0.223 (0.530) 0.350 (0.197) 0.398 (0.224) 173 
Gleason 4 0.031 (0.055) 0.203 (0.500) 0.333 (0.194) 0.433 (0.252) 135 
Gleason 5 0.034 (0.062) 0.183 (0.467) 0.325 (0.196) 0.457 (0.275) 95 
Gleason 6 0.037 (0.070) 0.164 (0.432) 0.318 (0.198) 0.481 (0.300) 65 
Gleason 7 0.040 (0.079) 0.144 (0.394) 0.298 (0.193) 0.518 (0.335) 45 
Gleason 8 0.043 (0.088) 0.124 (0.353) 0.278 (0.187) 0.555 (0.373) 32 
Gleason 9 0.046 (0.099) 0.100 (0.299) 0.253 (0.179) 0.601 (0.424) 25 
Gleason 10 0.049 (0.111) 0.076 (0.239) 0.228 (0.169) 0.647 (0.481) 20 
  
Figure Captions 
Fig. 1 Block diagram of the model for prostate diffusion. The model consists of four 
compartments, vascular, fluid filled ductal lumen, stroma and epithelium. Water 
exchange between both the vascular space and the ductal lumen and the other 
compartments is assumed to be negligible. Exchange between stroma and epithelium 
occurs but the two are not well mixed. 
Fig. 2 Flow chart of the method used to determine empirical parameters of the diffusion 
model. 
Fig. 3 Plot comparing measured values of measured ADC (Dmeasured) with values predicted 
by the model (Dmodel). Measurements made at 1.5T and 3T respectively are in blue 
and red respectively. Triangles and circles represent Category I (measurements 
represent a single Gleason score) and II (measurements represent an average Gleason 
score) papers respectively. The solid line is the line of identity.  
Fig. 4 Bland-Altman plot of ADC difference, Dmodel – Dmeasured, vs. mean, (Dmodel + D-
measured)/2. Measurements made at 1.5T and 3T respectively are in blue and red 
respectively. Triangles and circles represent Category I (measurements represent a 
single Gleason score) and II (measurements represent an average Gleason score) 
papers respectively. The solid, dotted and dashed lines represent the mean difference, 
and the mean ± 1.96 standard deviations (i.e., the 95% confidence limits) respectively.  
Fig. 5 Plot of ductal, epithelial, stromal and cellular (stromal and epithelial combined) ADC 
and cellular kurtosis vs. Gleason score. A score of 0 corresponds to normal peripheral 
zone tissue. 
Fig. 6 Plot of signal vs. b value for normal peripheral zone (PZ) and Gleason scores 5 – 9. 
Note the discontinuity near b = 0 due to the delta function in Eq. [3]. 
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